In 2019, Dr. Akbar allegedly issued prescriptions for tramadol, a Schedule IV opioid, and lorazepam, a Schedule IV benzodiazepine, to an undercover Drug Enforcement Administration Task Force Officer over the course of four meetings. The government alleged these prescriptions were not for a legitimate medical purpose.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
